The Frequency of Thyroid Diseases in Women With Breast Cancer
NCT ID: NCT04406779
Last Updated: 2020-05-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
160 participants
OBSERVATIONAL
2016-03-01
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Prospective Study of Hypothyroidism After Radiotherapy for Breast Cancer
NCT04528225
Thyroid Dysfunction in Women With Newly Diagnosed Breast Cancer Compared to Healthy Volunteers
NCT00336102
Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation
NCT02824016
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290
This Study is Mainly About Finding Incidence Among Other Factors of Thyroid Cancer in Patient with Benign Disease As MNG to Early Discover of the Malignancy to Save the Patient from Aggressive Procedure
NCT06730971
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with breast cancer
Patients with breast cancer
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
Control
Healthy patients without breast cancer
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
thyroid USG was perform, blood samples were taken for the meausurement of thyroid hormone and autoantibodies
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
65 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Uşak University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cevdet Duran
M.D.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UsakU-Cevdet1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.